阿斯利康.ppt

C:\Presentation\External\EMBA lecture_11/ Tong university- 1 -创新,全球化的动力柯石谛阿斯利康中国(含香港地区)总裁交通大学8 November 2003C:\Presentation\External\EMBA lecture_11/ Tong university- 2 -创新–全球化的动力Innovation – the Driving Force behind Globalization制药行业The Pharma industry制药行业的创新Innovation in the pharma-industry什么是全球化?What is globalization?国际企业中的领导力Leadership in a pany中国的制药行业Pharma market in ChinaQ & AC:\Presentation\External\EMBA lecture_11/ Tong university- 3 -创新和全球化Innovation and Globalization创新和全球化是相互依存、相互促进的Innovation and globalization are mutually dependent and enabling只有不断创新的企业才能在全球获得成功Only panies can essfully panies are more able to afford and recover the higher and higher cost of innovation创新Innovation全球化GlobalizationC:\Presentation\External\EMBA lecture_11/ Tong university- 4 -我们的目标Our Ambition一个富于创新的、快速的和高效的公司,凭借其全球范围内的销售和市场方面的优势,充分挖掘并实现研发的巨大潜力,从而提供持续的、顶尖的财政增长。A creative, fast and pany with the global sales and marketing strength to realize the full potential from productive R&D – thereby delivering sustainable top tier financial Tom McKillopCEO AstraZenecaOctober 2003C:\Presentation\External\EMBA lecture_11/ Tong university- 5 -阿斯利康工作重点AZ’ s Key Business Priorities不断增加的鼓东利益Increased Shareholder Value快速、有效的组织机构Fast anization关键产品的增长Growth through Key Products全球范围的成功Win Globally顾客首选的合作伙伴First Choice for Customers源源不断的新产品Secure Flow of New Products建立人才储备Build Talent BaseC:\Presentation\External\EMBA lecture_11/ Tong university- 6 -制药行业的结构- 2002Pharma Industry Structure - 2002“BIG”Pharma 58%?13家企业?MS介于3%和11%之间第二阶梯制药企业21%?19家欧盟企业?6家美国企业?23日本企业生物技术3%仿制药生产厂家5%“Rats & Mice”13%?近300家企业?In-licensing?Early stage collaboration?TechnologyLicensing?18家企业?%%之间C:\Presentation\External\EMBA lecture_11/ Tong university- 7 -阿斯利康2002年关键的统计数据AstraZeneca 2002 Key Statistics178亿的销售额Sales of billion营运利润44亿美元Operating profit of $ billion全球58000员工58,000 employees worldwide研发费用超过30亿–销售额的17